PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PROCAINE AND COMPOUNDS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 847 records · Page 47Linked to original sources

Limited nerve impulse blockade by "leashed" local anesthetics.

To measure the depth of the local anesthetic binding site within the neuronal membrane, biotin-containing polyethylene glycols having zero, three, and six ethylene glycol subunits were added to the p-amino termini of tetracaine and procaine, thereby interposing a pharmacologically inert "spacer" molecule between the local anesthetic and the biotin moiety. These biotinyl-local anesthetic derivatives produced "tonic" inhibition of the compound action potential of split, desheathed frog sciatic nerves in a concentration-dependent, reversible manner. However, no inhibition of the action potential occurred when sufficient avidin, a 66,000-MW protein that binds four biotins, was present to bind and anchor the biotin-containing end of each derivative outside the plasma membrane. Increasing the "leashed" anesthetic derivative's concentration to 4 times that which reduced impulse height by 50% in the absence of avidin still produced no detectable block when equimolar avidin was present. Apparently, the "spacer" in the derivative compound was too short to permit the avidin-complexed anesthetic to reach its site of action on the sodium channel. In a similar fashion, the local anesthetic derivatives produced "use-dependent" block when drug-treated nerves were stimulated at 40 Hz in the absence of equimolar avidin, but failed to produce "use-dependent" block when equimolar avidin was present. In common with others, we assume that tertiary amine local anesthetics may reach their binding site via hydrophobic (transmembrane) pathways without necessarily entering the cytoplasm. Thus, since our longest local anesthetic derivative, that containing six ethylene glycol subunits, placed the local anesthetic group a maximum of 15-18 A from the surface of the avidin moiety, we conclude that the local anesthetic binding site for block of sodium channels of amphibian nerve must be greater than or equal to 15 A from the outer surface of the plasma membrane.

Action Potentials↗

Studies on the mechanism of spasmolytic activity of (O-methyl-)-N-(2,6-dihydroxybenzoyl)tyramine, a constituent of Aniba riparia (Nees) Mez. (Lauraceae), in rat uterus, rabbit aorta and guinea-pig alveolar leucocytes.

The mechanism of action of a nonspecific smooth muscle relaxant, (O-methyl-)-N-(2,6-dihydroxybenzoyl)tyramine (riparin), a constituent of Aniba riparia (Nees) Mez. (Lauraceae) was studied in relation to Ca2+ metabolism in smooth muscle tissues and in guinea-pig alveolar leucocytes. In rat depolarized uterus, riparin inhibited in a reversible and noncompetitive manner CaCl2-induced contraction, a response mediated through voltage-dependent Ca2+ channels. The pD2 value (mean +/- s.e.m.) for riparin was 4.98 +/- 0.06. When compared with sodium nitroprusside (IC50 2.5 microM), an antagonist of receptor-operated Ca2+ channels, riparin was ineffective in suppressing noradrenaline-induced sustained contractions of rabbit aortic strips. However, in the aorta, the compound inhibited intracellular calcium-dependent transient contractions of noradrenaline and riparin (IC50 10.1 microM) was approximately two and a half times more potent than procaine (IC50 25.5 microM) a known inhibitor. In guinea-pig alveolar leucocytes, riparin (IC50 3.2 microM) inhibited intracellular Ca2+ accumulation induced by the calcium ionophore A23187. The results suggest that the inhibition of Ca2+ influx and of Ca2+ release from intracellular stores contribute to the spasmolytic effects of riparin, which may not involve cyclic AMP generation as the levels of this nucleotide were not increased in alveolar macrophages treated with riparin (10-100 microM).

Animals↗

Reactions with dye free radicals reveal weak redox properties of drugs.

The calcium release channel (CRC) of the skeletal sarcoplasmic reticulum is rich in thiol groups and is strongly regulated by covalent modification of these thiols. Oxidizing reagents activate the release channel, whereas reducing reagents inhibit the channel. However, most CRC regulators are not thiol reagents. Here, we propose that reversible redox interactions are involved in regulation of the CRC by nonthiol reagents. This hypothesis was tested with several CRC regulators. The local anesthetics tetracaine, procaine and QX-314, which block the CRC, behaved as electron donors in reactions with dye free radicals. In contrast, ryanodine, caffeine, doxorubicin and daunorubicin, compounds known to activate the release channel, all accepted electrons from dye anion radicals. Moreover, release of Ca2+ from SR initiated by doxorubicin (acceptor) was antagonized by local anesthetics (donors). Based on the redox characterization of CRC modulators, we propose a functional model in which channel inhibitors and activators act as weak electron donors and acceptors, respectively, and shift the thiol-disulfide balance within the release protein. The consequence of this model is that, in spite of the chemical diversity of CRC modulators, a common mechanism of channel regulation involves the transient exchange of electrons between the activator/inhibitor and the CRC.

Anesthetics, Local↗

Modification of drug metabolic processes by compounds which intervene with the function of cytochrome P-450 as a mono-oxygenase and as an oxidase.

Pregnenolone-16 alpha-carbonitrile, spironolactone, tocopherol acetate and ethanol were tested for their effect on lipid peroxidation using microsomal membranes or linoleic acid as substrates and Fe++/ascorbate or Fe++ as electron sources. The steroids had no effect on lipid peroxidation, tocopherol and ethanol presented potent and mild antioxidant activity, respectively. Pregnenolone-16 alpha-carbonitrile, spironolactone, ethanol and tocopherol acetate were examined for the effects on the body's response to drugs. It was found that the former three agents increased the resistance to zoxazolamine, hexobarbital and chlorzoxazone and tocopherol acetate increased only that against chlorzoxazone. The test compounds were examined for their effect on the in vivo reduction of p-nitrobenzoate and the in vitro metabolism of zoxazolamine, hexobarbital, ethylmorphine and procaine. The two steroids and ethanol enhanced the metabolism almost in all cases, while tocopherol acetate increased only ethylmorphine N-demethylation very significantly.

Animals↗

Mechanism of mesaconitine-induced contractile response in guinea pig vas deferens.

Mesaconitine (MA) caused contraction of the isolate guinea pig vas deferens in a dose-dependent manner (3 x 10(-6) - 10-(-4) g/ml) and nonspecifically potentiated the contractile response to norepinephrine (NE), acetylcholine, histamine and tyramine. Tachyphylaxis developed during the repeated application of MA. The contraction produced by MA was prevented by treatment with phentolamine, phenoxybenzamine, procaine, bretylium or tetrodotoxin, pretreatment with reserpine or 6-hyroxydopamine, or denervation. Atropine or hexamethonium did not abolish the effect of MA, excluding the possibility that the muscarinic and nicotinic receptors are the site of action of MA. MA elicited a dose-dependent release of NE from the isolated vas deferens which had been blocked by treatment with tetrodotoxin, pretreatment with reserpine, or the exclusion of calcium ion from the bath medium. Consequently, it is concluded that MA-induced contraction was brought about by the release of NE from pre-synaptic neuronal sites and by excitation of the post-synaptic membrane.

Aconitine↗

Properties of acetylcholinesterase in lobster axonal membrane.

1. Acetylcholinesterase (AChE) activity of axonal membrane vesicles prepared from lobster (Homarus americanus) walking leg nerve is about 200 mumol ACh/hr/mg protein. 2. The enzyme is a membrane-bound glycoprotein that can be solubilized by lysolecithin and digitonin but is rapidly inactivated by Triton X-100 and other nonionic detergents. 3. The walking leg nerve enzyme contrasts most markedly with postsynaptic AChE in its lack of inhibition by excess substrate and its poor susceptibility to peripheral anionic site ligands. 4. Axonal AChE is competitively blocked by eserine sulfate (1 microM) and by low concentrations of procaine (0.1-0.5 mM). 5. Lidocaine, a tertiary amine, and its quaternary ammonium derivative QX-314 are equipotent non-competitive enzyme inhibitors (Kiapp 2-3 mM), while the primary amine compound GX-HCl is totally inactive. 6. Calcium (10 50 mM), propidium (1 microM) and decamethonium (1 microM), peripheral anionic site ligands in the synaptic enzyme, do not protect the axonal enzyme against inhibition by local anesthetics. 7. Although it is possible that this enzyme is an isozyme of the true AChE of excitable membranes, or that it is an incomplete enzyme fragment, it is also possible that there is a unique membrane-bound AChE present in large quantities in crustacean peripheral nerve.

Acetylcholinesterase↗

Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.

Methylation-associated silencing of tumor suppressor genes is recognized as being a molecular hallmark of human cancer. Unlike genetic alterations, changes in DNA methylation are potentially reversible. This possibility has attracted considerable attention from a therapeutics standpoint. Nucleoside-analogue inhibitors of DNA methyltransferases, such as 5-aza-2'-deoxycytidine, are able to demethylate DNA and restore silenced gene expression. Unfortunately, the clinical utility of these compounds has not yet been fully realized, mainly because of their side effects. A few non-nucleoside inhibitors of DNA methyltransferases have been reported, including the anti-arrhythmia drug procainamide. Following this need to find new demethylating agents, we have tested the potential use of procaine, an anesthetic drug related to procainamide. Using the MCF-7 breast cancer cell line, we have found that procaine is a DNA-demethylating agent that produces a 40% reduction in 5-methylcytosine DNA content as determined by high-performance capillary electrophoresis or total DNA enzyme digestion. Procaine can also demethylate densely hypermethylated CpG islands, such as those located in the promoter region of the RAR beta 2 gene, restoring gene expression of epigenetically silenced genes. This property may be explained by our finding that procaine binds to CpG-enriched DNA. Finally, procaine also has growth-inhibitory effects in these cancer cells, causing mitotic arrest. Thus, procaine is a promising candidate agent for future cancer therapies based on epigenetics.

Antineoplastic Agents↗

Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action.

Prostaglandin E1 (PGE1) altered both the amplitude and conduction velocity of the compound action potential in frog sciatic nerve. Concentrations up to 1 ng/ml increased both amplitude and conduction velocity but at higher concentrations both effects were reversed. Procaine, chloroquine, indomethacin and SC19220 all reduced action potential amplitude and conduction velocity. These local anaesthetic type actions could be partially or completely prevented by PGE1.

Action Potentials↗